249 related articles for article (PubMed ID: 12668792)
1. Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial.
Roberts G; Newsom D; Gomez K; Raffles A; Saglani S; Begent J; Lachman P; Sloper K; Buchdahl R; Habel A;
Thorax; 2003 Apr; 58(4):306-10. PubMed ID: 12668792
[TBL] [Abstract][Full Text] [Related]
2. Aminophylline, salbutamol and combined intravenous infusions in acute severe asthma.
Evans WV; Monie RD; Crimmins J; Seaton A
Br J Dis Chest; 1980 Oct; 74(4):385-9. PubMed ID: 7011354
[TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial of aminophylline for severe acute asthma.
Yung M; South M
Arch Dis Child; 1998 Nov; 79(5):405-10. PubMed ID: 10193252
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute asthma. Lack of therapeutic benefit and increase of the toxicity from aminophylline given in addition to high doses of salbutamol delivered by metered-dose inhaler with a spacer.
Rodrigo C; Rodrigo G
Chest; 1994 Oct; 106(4):1071-6. PubMed ID: 7924475
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
Browne GJ; Trieu L; Van Asperen P
Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of intravenous salbutamol in early management of acute severe asthma in children.
Browne GJ; Penna AS; Phung X; Soo M
Lancet; 1997 Feb; 349(9048):301-5. PubMed ID: 9024371
[TBL] [Abstract][Full Text] [Related]
7. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
8. Intravenous aminophylline confers no benefit in acute asthma treated with intravenous steroids and inhaled bronchodilators.
Coleridge J; Cameron P; Epstein J; Teichtahl H
Aust N Z J Med; 1993 Aug; 23(4):348-54. PubMed ID: 8240146
[TBL] [Abstract][Full Text] [Related]
9. Effect of adding aminophylline infusion to nebulised salbutamol in severe acute asthma.
Zainudin BM; Ismail O; Yusoff K
Thorax; 1994 Mar; 49(3):267-9. PubMed ID: 8202885
[TBL] [Abstract][Full Text] [Related]
10. Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma.
D'Avila RS; Piva JP; Marostica PJ; Amantea SL
Respir Med; 2008 Jan; 102(1):156-61. PubMed ID: 17869497
[TBL] [Abstract][Full Text] [Related]
11. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators.
Mitra A; Bassler D; Goodman K; Lasserson TJ; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD001276. PubMed ID: 15846615
[TBL] [Abstract][Full Text] [Related]
12. Intravenous beta(2)-agonists versus intravenous aminophylline for acute asthma.
Travers AH; Jones AP; Camargo CA; Milan SJ; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010256. PubMed ID: 23235686
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of intravenous salbutamol and aminophylline in acute asthma.
Tribe AE; Wong RM; Robinson JS
Med J Aust; 1976 Nov; 2(20):749-52. PubMed ID: 794661
[TBL] [Abstract][Full Text] [Related]
14. Intravenous aminophylline for acute severe asthma in children over 2 years using inhaled bronchodilators.
Mitra A; Bassler D; Ducharme FM
Cochrane Database Syst Rev; 2001; (4):CD001276. PubMed ID: 11687103
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus.
Bogie AL; Towne D; Luckett PM; Abramo TJ; Wiebe RA
Pediatr Emerg Care; 2007 Jun; 23(6):355-61. PubMed ID: 17572517
[TBL] [Abstract][Full Text] [Related]
16. Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations.
Strauss RE; Wertheim DL; Bonagura VR; Valacer DJ
Pediatrics; 1994 Feb; 93(2):205-10. PubMed ID: 8121733
[TBL] [Abstract][Full Text] [Related]
17. Magnesium sulphate in acute severe asthma in children (MAGNETIC): a randomised, placebo-controlled trial.
Powell C; Kolamunnage-Dona R; Lowe J; Boland A; Petrou S; Doull I; Hood K; Williamson P;
Lancet Respir Med; 2013 Jun; 1(4):301-8. PubMed ID: 24429155
[TBL] [Abstract][Full Text] [Related]
18. Intravenous beta agonist in severe acute asthma.
Cheong B; Reynolds SR; Rajan G; Ward MJ
BMJ; 1988 Aug; 297(6646):448-50. PubMed ID: 3139138
[TBL] [Abstract][Full Text] [Related]
19. The administration of beta2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand emergency departments: a cross-sectional survey.
Habashy D; Lam LT; Browne GJ
Eur J Emerg Med; 2003 Sep; 10(3):219-24. PubMed ID: 12972899
[TBL] [Abstract][Full Text] [Related]
20. Low-dose l-isoproterenol versus salbutamol in hospitalized pediatric patients with severe acute exacerbation of asthma: A double-blind, randomized controlled trial.
Katsunuma T; Fujisawa T; Maekawa T; Akashi K; Ohya Y; Adachi Y; Hashimoto K; Mizuno M; Imai T; Oba MS; Sako M; Ohashi Y; Nakamura H
Allergol Int; 2019 Jul; 68(3):335-341. PubMed ID: 30846304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
